Next Article in Journal
Solid-State Fermentation of Jatropha curcas Cake by Pleurotus ostreatus or Ganoderma lucidum Mycelium to Determine Multi-Bioactivities
Previous Article in Journal
Inorganic Arsenic in Rice-Based Beverages: Occurrence in Products Available on the Italian Market and Dietary Exposure Assessment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antimicrobial Effect of Postbiotics on Multidrug-Resistant Escherichia coli

by
Çiğdem Sezer
1,*,
Nebahat Bilge
1,
Gönül Damla Büyük
1 and
Merve Ayyıldız Akın
2
1
Department of Food Safety and Public Health, Faculty of Veterinary Medicine, Kafkas University, 36100 Kars, Türkiye
2
Department of Biostatistics, Faculty of Veterinary Medicine, Kafkas University, 36100 Kars, Türkiye
*
Author to whom correspondence should be addressed.
Foods 2026, 15(2), 384; https://doi.org/10.3390/foods15020384
Submission received: 28 December 2025 / Revised: 14 January 2026 / Accepted: 19 January 2026 / Published: 21 January 2026
(This article belongs to the Section Food Microbiology)

Abstract

Pathogens that have developed resistance to antibiotics pose a threat to public health. The primary goal in preventing foodborne infections is to inhibit the growth of and, subsequently, eliminate antibiotic-resistant pathogens at every stage from production to consumption. Escherichia coli, which has acquired resistance to most known antibiotics, is frequently found in chicken meat. In many countries, due to unregulated antibiotic use in poultry farming, poor hygiene in slaughterhouses, or cross-contamination, extended-spectrum beta-lactamase (ESBL)-producing E. coli has been identified as the causative agent in poultry-associated food poisoning. The need for more effective antimicrobial agents against this pathogen, which is resistant to existing antibiotics, has led to increased attention being paid to postbiotics produced by lactic acid bacteria, particularly bacteriocins. This study aimed to determine the antimicrobial effects of postbiotics obtained from kefir-derived Lactiplantibacillus plantarum and Lactococcus lactis against ESBL-positive E. coli. To achieve this, E. coli strains were isolated from raw chicken meat samples collected from the market using culture-based methods, and their antimicrobial resistance profiles were determined using the disk diffusion method. The ESBL positivity of the isolates was assessed using the double-disk synergy test. The antimicrobial activities of the postbiotics against the identified ESBL-positive E. coli strains were tested using the macro-dilution method to determine minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values. ESBL-positive E. coli was detected in 48% of raw chicken meat samples. The antimicrobial effects of postbiotics were examined by disk diffusion, and postbiotics produced by 18 Lb. plantarum strains and 20 Lc. lactis strains showed strong antimicrobial activity. Significant differences in the antimicrobial effects of postbiotics were observed between the two species. Lb. plantarum postbiotics exhibited both bacteriostatic (concentration 60%) and bactericidal (concentration 80%) effects on ESBL-positive E. coli strains, whereas Lc. lactis postbiotics showed only bacteriostatic effects (80% concentration). Postbiotics derived from probiotic bacteria offer promising effects against multidrug-resistant E. coli due to their heat resistance, activity across different pH values, strong antimicrobial effects, affordability, and ease of production.

1. Introduction

Antimicrobial resistance is a global problem for public and animal health in both developed and developing countries worldwide. It is known that antibiotic-resistant microorganisms can spread through animal products and humans [1]. If effective strategies to slow the increase in antimicrobial resistance are not found, it is estimated that millions of people could be at risk of death in the coming decades due to the rise in antimicrobial-resistant infections [2]. Antimicrobials are used worldwide, particularly in poultry, to treat bacterial infections, prevent infections, and promote growth [1,3]. The European Union prohibited the prophylactic use of antibiotics in animal feed in 2006 [4]. In the United States, one of the largest poultry producers, the FDA, has taken several key measures to ensure the appropriate and rational use of medically important antimicrobial drugs in poultry. In its 2015 veterinary feed directive, the FDA prohibited the prophylactic use of antibiotics and stipulated that antimicrobials can only be administered with a veterinary prescription [5]. Despite these regulatory measures, antimicrobial-resistant bacteria and the infections they can cause, which represent a global threat, endanger both public health and food safety. Although the OECD-FAO Agricultural Outlook 2022–2031 report states that poultry meat will lead the growth of the meat sector [6], many studies have shown that antibiotic-resistant pathogens in chicken meat are a major public health problem. The presence of extended-spectrum beta-lactamase (ESBL)-producing E. coli in chicken meat has been reported in numerous studies [7,8,9,10,11,12,13]. The presence of such high levels of antimicrobial-resistant microorganisms in chicken meat, which is a popular food, poses a considerable risk to public health. Tsitsos et al. (2025) investigated the presence of antibiotic-resistant E. coli in chicken meat and examined the relationships of the isolates obtained according to regions and seasons [13]. Through protein profile analysis, they revealed the relatedness of isolates obtained in different seasons and regions. Based on these results, they emphasized that poultry meat is a very important reservoir for resistant E. coli and that all necessary hygiene measures should be taken to protect public health [13]. Schwaiger et al. (2012) reported that antimicrobial-resistant E. coli were predominantly found in chicken meat samples collected from poultry slaughterhouses and retail outlets, and that it was difficult to determine the precise stage in the production chain at which contamination occurred [14]. Kim et al. (2020) investigated the presence of antimicrobial-resistant E. coli in chicken meat sold in Korea and obtained noteworthy results [15]. In their study, chicken meat from standard poultry farms, as well as meat labeled as organic or antibiotic-free, was included in the research groups. According to the study data, antimicrobial-resistant E. coli were found in high amounts in all three groups of chicken meat. Based on these findings, it was concluded that the contamination likely originated from the slaughterhouse [15]. A similar study was conducted in Canada by Chalmers et al. (2021) [16]. Ceftiofur use in poultry farming was prohibited in Canada in 2014; yet several years after this, these researchers isolated extended-spectrum cephalosporin-resistant E. coli from the feces of chickens raised with and without therapeutic antimicrobials for two years and noted that both rearing methods yielded similar results [16]. Projahn et al. (2019) investigated cross-contamination of antibiotic-resistant E. coli before and after slaughter in two different broiler flocks (ESBL-negative) that were monitored and analyzed at a slaughterhouse [17]. Through phylogenetic analysis, they determined that the slaughterhouse (particularly the feather-plucking and scalding water stages) was a significant source of contamination during poultry processing [17]. Zhao et al. (2024) conducted a study analyzing the genes of antimicrobial-resistant E. coli in retail chicken meat [18]. Their comparative analysis of chicken meat-derived and human-derived E. coli revealed that plasmids carrying mcr-1 or blaNDM from E. coli obtained from chicken meat showed high similarity to plasmids obtained from human-derived Enterobacteriaceae. This result clearly demonstrates the risk of mcr-1 or blaNDM transmission from retail meat to humans. The simultaneous presence of mcr-1 and blaNDM in E. coli highlights a serious threat to public health and emphasizes the importance of antimicrobial resistance surveillance in retail meats [18]. The WHO states that antimicrobial resistance is one of the top 10 public health threats facing humanity and emphasizes the vital importance of conducting research to discover and develop new antimicrobials [19]. Two possible solutions have been envisioned for the problem of antimicrobial resistance in pathogens for which known antibiotics are ineffective: either more potent chemicals/antibiotics will be discovered, or very detailed research will be conducted on the usability of natural antimicrobial compounds. To this end, research has long focused on bacteriocins and postbiotics produced by lactic acid bacteria. Different data exist regarding the stability (temperature, pH, enzyme, etc.), antimicrobial activity, mode of action (Gram-negative or Gram-positive cell structure), and application method of each bacteriocin [20,21,22,23]. Although the effects of postbiotics depend on several factors, such as the target microorganism and the method of application, the most critical factor to be considered is the accurate selection of the bacteriocin-producing strain. The primary objective of this study is to isolate lactic acid bacteria with antimicrobial activity (Lb. plantarum and Lc. lactis) from kefir, a probiotic food containing a wide variety of lactic acid bacteria, and to evaluate the antimicrobial effects of the postbiotics produced by these bacteria against ESBL-producing E. coli. In addition, when selecting alternative antimicrobial agents for the food industry, not only strong antimicrobial activity but also economic feasibility and practical applicability are of great importance. In many similar studies aiming to develop alternative antimicrobials, the focus has been on bacteriocins and their purified forms. In contrast, this study investigates the direct applicability of postbiotics without the need for bacteriocin purification, focusing on their stability under different heat treatments, resistance over time, and related practical properties.

2. Materials and Methods

2.1. Materials

In the study, samples of fresh-cut (non-frozen) chicken thighs and/or wings from different brands and batch numbers were collected from ten retail outlets. A total of 100 samples were transported to the laboratory under cold-chain conditions as quickly as possible, and the samples were kept at 4 °C throughout the study period. Kefir samples were produced under laboratory conditions using UHT milk and kefir grains obtained from five different sources (3%, w/v). Fermentation was carried out at 30 °C for 18, 24, and 48 h, and the resulting kefir samples were used for further analyses.

2.2. Methods

2.2.1. Isolation and Identification of E. coli from Chicken Samples

For the isolation of E. coli, at least 50 g of each chicken sample was homogenized with nine volumes of Tryptic Soy Broth (TSB) to prepare decimal dilutions. Aliquots were spread onto two Violet Red Bile Lactose Agar (VRBA) plates. One plate was incubated at 44.5 °C and the other at 35–37 °C for 18–24 h. Following incubation, typical colonies were purified and stored as stock cultures. Identification was performed using conventional biochemical tests, including Gram staining, oxidase, catalase, and IMViC tests [24]. E. coli ATCC 25922 was used as a positive control.

2.2.2. Isolation and Identification of Lb. plantarum and Lc. lactis from Kefir

In our previous study [25], bacteriocins produced by Lb. plantarum and Lc. lactis among lactic acid bacteria were found to exhibit broad-spectrum antimicrobial activity. Therefore, the isolation of these two lactic acid bacteria was specifically targeted in this study.
In this study, different kefir samples were obtained using kefir grains from five different sources. The kefir grains were fermented in sterile milk at 30 °C, and samples were taken from the kefirs at the 18th, 24th, and 48th hours of fermentation (to enhance the probability of isolating the target lactic acid bacteria). These samples were then plated onto MRS Agar and M17 Agar media and incubated at 30 °C for 48–72 h. At the end of incubation, typical colonies were selected from each medium, purified, and stored as stock cultures. The obtained isolates were grouped using basic identification tests such as Gram staining, microscopic morphology, catalase reaction, oxidase test, and glucose gas production [26]. Molecular identification was carried out by PCR following DNA extraction using a commercial kit (QIAGEN, QIAamp-51304, Venlo, The Netherlands). The PCR mix and conditions described by Torriani et al. (2001) and Pu et al. (2002) were used with minor modifications [27,28]. For Lb. plantarum (amplicon 318 bp.), planF (5′-CCG TTT ATG CGG AAC ACC TA-3′) and pREV (5′-TCG GGA TTA CCA AAC ATC AC-3′) primers were used, while for Lc. lactis (amplicon 161 bp.), LacreR (19-GGGATCATCTTTGAGTGAT) and LacF (19-GTACTTGTACCGACTGGAT) primers were used [27,28,29]. In genetic identification tests, Lb. plantarum NRRL-B 4496 and Lc. lactis CECT 4432, obtained from the ARS culture collection, were used as positive controls. The primers used for the identification of Lb. plantarum and Lc. lactis are presented in Table 1.

2.2.3. Determination of the Antimicrobial Effects of Lb. plantarum and Lc. lactis on E. coli

The disk diffusion method was used to evaluate the antimicrobial activity of Lb. plantarum and Lc. lactis against E. coli. For this purpose, Lb. plantarum and Lc. lactis were cultured in MRS broth at 30 °C for 18 h. Lactic acid bacteria cultures were centrifuged at 10.000× g for 10 min at 4 °C. The supernatants were collected and sterilized by microfiltration. E. coli suspensions in TSB adjusted to McFarland 0.5 were inoculated onto Mueller–Hinton Agar. After inoculating 100 μL of E. coli strain cultures, 100 μL samples of sterile supernatants of LAB were inoculated onto blank paper disks placed at specific intervals on the Mueller–Hinton Agar surface. Plates were incubated at 35–37 °C for 24–48 h, and after incubation, any zones around the disk were examined, and their diameters were measured [25]. The presence of any inhibition zone was considered indicative of antimicrobial activity. According to the CLSI-2024 and EUCAST-2025 guidelines [30,31], the maximum measurable diameter indicating resistance to various antibiotics was defined as ≥2.7 cm. Therefore, when evaluating the effects of postbiotics, an inhibition zone diameter of ≥2.7 cm was considered to represent a strong antimicrobial effect. The existing antimicrobial effect may be due to low pH value, the possible presence of hydrogen peroxide, or bacteriocins with a protein structure. To differentiate these effects, fresh cultures were prepared separately for Lb. plantarum and Lc. lactis isolates showing antimicrobial activity, and their supernatants were obtained by centrifugation. The supernatants, which were sterilized by microfiltration, were subjected to pre-treatment (pH neutralization, application of 1 mg/mL catalase to neutralize possible hydrogen peroxide, and application of proteolytic enzymes, including of 1 mg/mL protease), and the antimicrobial effect was retested after treatment using the method described above. Loss of the antimicrobial activity following protease treatment revealed that the antimicrobial effect originated from a protein-structured compound. Following this stage, considering the applicability criteria (practicality and cost) in the poultry sector, the purification processes of the detected bacteriocins were not carried out, and the study continued with sterile supernatants. Furthermore, to determine some of the properties of the supernatants, antimicrobial activity stability tests were applied to the supernatants after different heat treatments (65 °C for 30 min/115 °C for 15 min). After this stage, these neutralized and sterilized supernatants were subsequently referred to as postbiotics [25].

2.2.4. Antimicrobial Resistance Determination Tests

The Kirby–Bauer disk diffusion method was used to determine the antimicrobial resistance of E. coli strains isolated from chickens. Antimicrobial susceptibility tests were performed on 16 antibiotic agents representing different antibiotic groups: Meropenem (10 μg), Ciprofloxacin (5 μg), Aztreonam (30 μg), Gentamicin (10 μg), Netilmicin (10 μg), Amikacin (30 μg), Ampicillin (10 μg), Ticarcillin/Clavulanate (75–10 μg), Chloramphenicol (30 μg), Trimethoprim/sulfamethoxazole (125–23.75 μg), Cefoxitin (30 μg), Cefotaxime (5 μg), Cephalothin (30 μg), Cefpodoxime (10 μg), Ceftazidime (10 μg), and Ceftriaxone (30 μg). Fresh cultures of the test strains were prepared in saline solution with concentration adjusted to McFarland 0.5 (approximately 1–2 × 108 cfu/mL) and plated on Mueller–Hinton agar using a sterile swab. After plating, antibiotic disks were also placed on the plates, and the plates were incubated at 35 °C for 18 ± 2 h [32]. At the end of incubation, zone diameters were measured and evaluated according to CLSI-2024 and EUCAST-2025 data [30,31]. Klebsiella pneumoniae ATCC 700603, E. coli ATCC 35218, and E. coli ATCC 25922 were used as control strains in the tests. In E. coli strains showing resistance as a result of antibiotic resistance tests, the presence of broad-spectrum beta-lactamase was investigated.

2.2.5. Detection of Extended-Spectrum Beta-Lactamase-Producing E. coli

ESBLs are enzymes that hydrolyze most penicillins and cephalosporins, including oxime-beta-lactams, but are unaffected by cefamycins and carbapenems, and are inhibited by clavulanic acid, sulbactam, and tazobactam. The double-disk synergy method was used to detect ESBLs in E. coli strains. Cephalosporins ceftriaxone, cefotaxime, ceftazidime, and cefpodoxime were used with amoxicillin–clavulanic acid. The Kirby–Bauer disk diffusion method was used for the test. Fresh cultures of E. coli isolates were prepared. Concentrations were adjusted to McFarland 0.5 in physiological saline and inoculations were performed on Mueller–Hinton agar using sterile swabs. After inoculation, ceftriaxone, cefotaxime, ceftazidime, and cefpodoxime, along with amoxicillin–clavulanic acid disks, were placed in plates, and the plates were incubated at 35–37 °C for 18 ± 2 h [32]. At the end of incubation, zone diameters were measured, and if the zone of any of the cephalosporin disc increased toward the clavulanic acid disc, the result was considered ESBL-positive [33].

2.2.6. Determination of the Antimicrobial Effect of Postbiotics on ESBL-Positive E. coli

In this phase of the study, the macro-dilution method was used to investigate the effects of postbiotics, which were found to exert antimicrobial activity against the reference E. coli strains ATCC 35218 and ATCC 25922, on E. coli isolates obtained from chicken meat samples which were determined to have developed multidrug resistance [34]. For this purpose, multidrug-resistant E. coli isolates adjusted to McFarland 0.5 were inoculated (in quantities of 100 µL) into solutions of Lb. plantarum and Lc. lactis postbiotics prepared in different concentrations (1.25–100%) in Mueller–Hinton broth, and the tubes were incubated at 35 °C. Evaluations were performed at 0, 6, 12, 24, 48, and 72 h of incubation. The lowest postbiotic concentration showing no growth in the tubes was determined as the minimum inhibitory concentration (MIC) value. The tubes showing no growth were subsequently plated on Mueller–Hinton agar, and the plates were incubated at 35 °C for 12–24 h. The lowest concentration showing no bacterial growth after incubation was determined as the minimum bactericidal concentration (MBC) value. For this assay, Mueller–Hinton broth without antimicrobial agent (postbiotic) and without bacteria (E. coli) inoculation was used as a negative control. Broth containing bacterial culture and broth containing antimicrobial agents were used as additional control groups.

2.2.7. Statistical Analysis

The G*Power 3.1.7.9 program was used to calculate the required sample size for this study. The minimum sample size was determined as 45 multidrug-resistant E. coli isolates, based on a test power of 0.95, an alpha error probability of 0.05, and an effect size of 0.50. All antimicrobial efficacy experiments were performed independently in triplicate. The data obtained in this study were analyzed using IBM SPSS statistics version 25.0. Descriptive statistics analyses were conducted for the evaluation. The normality of data distribution was assessed using the Kolmogorov–Smirnov test, and the result indicated that the data did not follow a normal distribution (p < 0.05). Therefore, continuous variables were summarized using median (Q1–Q3) values. Since the variables were categorical and the observations were independent, the Chi-square test—which is appropriate for testing differences in frequencies between categorical variables—was used to evaluate associations between groups. Categorical variables were expressed as frequencies and percentages. In addition to p-values, effect sizes were calculated to assess the strength of the associations. Cramer’s V was used as the measure of effect size, and effect sizes were interpreted as small, medium, or large. Descriptive statistics for continuous variables included the median, standard error, Q1–Q3, minimum, and maximum values, while distributions of categorical variables were presented as frequencies and percentages (%). A significance level of p < 0.05 was accepted for all analyses.

3. Results

A total of 125 E. coli isolates were identified in 83 (83%) of 100 raw chicken meat samples. All of these isolates were tested against 16 antibiotic agents. All isolates were susceptible to meropenem but resistant to aztreonam, cephalothin, cefoxitin, and ampicillin. Ampicillin resistance was inhibited by clavulanic acid in 70% of the isolates. Resistance to the fluoroquinolones, aminoglycosides, and other cephalosporins varied among the isolates. The antimicrobial susceptibility of the E. coli isolates is shown in Table 2.
The antimicrobial susceptibility and resistance profile of E. coli isolates is presented in Figure 1.
When all isolates were tested for ESBL production using the double-disk synergy method, 57 (45.6%) of the 125 isolates were determined to be ESBL-positive. The distribution rate of ESBL-positive isolates in chicken samples was found to be 48% (48 chicken samples). As a result of the cultural and molecular identification of 382 isolates obtained from kefir samples, 112 were identified as Lb. plantarum and 69 as Lc. lactis. The antimicrobial effects of these isolates and their postbiotics against E. coli used as reference strains were tested by the disk-diffusion method and it was determined that postbiotics produced by 18 Lb. plantarum strains and 20 Lc. lactis strains exhibited strong antimicrobial activity against the reference E. coli strains. A statistically highly significant difference was determined between the antimicrobial activity levels of the postbiotics produced by lactic acid bacteria (X2(2) = 178.472, p < 0.0001; Cramer’s V = 0.166). The effects of postbiotics on ESBL-positive E. coli strains were evaluated and the MIC and MBC values were determined. It was found that postbiotics of Lb. plantarum exerted both bacteriostatic and bactericidal effects on ESBL-positive E. coli strains, with the MIC value observed at 60% concentration and the MBC value at an 80% concentration. For Lc. lactis postbiotics, the MIC value was observed at an 80% concentration; however, this concentration was insufficient to achieve an MBC value. A significant finding was that the antimicrobial effect increased proportionally with increasing postbiotic concentration (X2(9) = 4417.18, p < 0.0001; Cramer’s V = 0.824).
The concentration- and time-dependent antimicrobial effects of postbiotics produced by lactic acid bacteria are presented in Table 3 and Table 4.
It was determined that Lc. lactis postbiotics exerted a bacteriostatic effect; however, considerably higher concentrations would be required to discuss a potential bactericidal effect. When the effect of incubation time on antimicrobial activity was evaluated, it was found that the antimicrobial effect began at the sixth hour of incubation, and prolongation of the incubation period did not result in either an increase or decrease in antimicrobial activity (X2(5) = 365.056, p < 0.0001; Cramer’s V = 0.237).
To describe the distribution of continuous variables in this study, the median, interquartile range (Q1–Q3), and minimum–maximum values were calculated. Descriptive statistics for these variables are presented in Table 5.

4. Discussion

The fact that foodborne illnesses often go unrecognized by healthcare professionals, and that food poisoning is not considered in cases of severe diarrhea, are common issues that hinder a comprehensive understanding of the relationship between contaminated food and public health [35]. According to WHO data, approximately 1 in 10 people worldwide suffer from food poisoning due to the consumption of contaminated food, and 420.000 people die each year as a result of foodborne diseases [36]. Salmonella, campylobacter, and enterohemorrhagic E. coli, which cause life-threatening diseases, are among the most common foodborne pathogens. In the modern era, there is a serious problem of resistance to antibiotics used against these pathogens. The unnecessary and excessive use of antibiotics in both human and veterinary medicine has led to the emergence of multidrug-resistant pathogens [36]. The WHO’s 2024 bacterial priority pathogens list includes ESBL-positive E. coli among pathogens that develop multidrug resistance [37]. In the present study, ESBL-positive E. coli was detected in 48% of the chicken samples. Considering that chicken meat is consumed by individuals of nearly all age groups, a prevalence rate of 48% is notably high. It should be noted that results vary between studies depending on differences in poultry rearing, slaughtering, and processing practices across countries and regions, as well as the sensitivity of the analytical methods employed. Indeed, previous studies have reported ESBL-positive E. coli prevalence rates ranging between 10% and 80% [38,39,40]. Randall et al. (2021), in studies conducted at different time intervals, reported that the prevalence of ESBL-producing E. coli in chicken meat was 65.4% in 2013, whereas following the implementation of rational antimicrobial use and regulatory measures, this rate decreased to 7.4% in 2018 [39]. The sources of ESBL-positive E. coli contamination in chicken meat may vary substantially [39]. Contamination can occur at multiple stages, ranging from evisceration and feather-plucking processes to food handlers and retail sales environments [41,42]. The aim of this study was to propose a natural and effective alternative antimicrobial agent that could be applied in poultry slaughterhouses against antibiotic-resistant E. coli isolates. The antimicrobial activity of postbiotics produced by probiotic strains isolated from different kefir samples is of significant interest from a public health perspective. In recent years, the potential applications of postbiotics produced by lactic acid bacteria in the food, pharmaceutical, and healthcare industries have been extensively investigated [43,44,45,46,47]. In this study, bacteriocins were identified as particularly effective postbiotic components due to their colorless and odorless nature, ease and low cost of production, and ability to retain antimicrobial activity following high-temperature treatment. When their antimicrobial effects were tested on E. coli, 18 of the 112 Lb. plantarum strains and 20 of the 69 Lc. lactis strains were found to be antimicrobial. Although previous studies have shown that postbiotics derived from lactic acid bacteria exhibit strong antimicrobial effects primarily against Gram-positive microorganisms, their efficacy against Gram-negative bacteria is generally limited due to the presence of an outer membrane. The antimicrobial action of bacteriocins occurs through disruption of cell wall biosynthesis or by forming pores in the cytoplasmic membrane, leading to impaired membrane permeability and cell death [25,48,49,50]. In the present study, a relatively small proportion of isolates (16% for Lb. plantarum and 28.9% for Lc. lactis) among a large number of kefir isolates were found to have antimicrobial effects against the E. coli reference strains and ESBL-positive E. coli isolates. The antimicrobial effect may be influenced by external factors such as the pH, temperature, salt concentration of the food/environment, as well as the cell wall structure characteristics of the target microorganism. The robust cell wall structure of Gram-negative bacteria poses a significant barrier to bacteriocin activity. Apart from the Gram-negative cell wall structure, differences in the structures of the bacteriocins themselves also indicate that their antimicrobial effect occurs through different mechanisms. Bacteriocins exert their effect by binding to Lipid II and/or the mannose phosphotransferase system in the cell wall, thus causing the formation of pores in the cell membrane during the peptidoglycan biosynthesis mechanism [51,52,53,54,55,56]. In terms of antimicrobial efficacy, the length of the incubation period (short or long) did not cause any change in the increase or decrease in antimicrobial efficacy. The antimicrobial efficacy observed within the first 6 h persisted throughout the 72-h incubated period. This finding suggests that postbiotics may exhibit antimicrobial performance comparable to that of conventional chemical antibiotics. We found that the antimicrobial efficacy on ESBL-positive E. coli isolates was both bacteriostatic and bactericidal in Lb. plantarum postbiotics, while the efficacy was only bacteriostatic in Lc. lactis postbiotics. From a public health perspective, these findings are highly significant. For Lb. plantarum postbiotics, it is certainly important that they are a strong and natural alternative to antibiotics in bacteria that have developed resistance to many antibiotics, but the fact that Lc. lactis postbiotics had only a bacteriostatic effect at the tested concentrations is also quite valuable information. The bacteriostatic effect can be particularly effective in controlling rapidly progressing infections and may help preserve beneficial gut microbiota that are often depleted during aggressive antibiotic treatments. Furthermore, slowing down the growth of pathogens in food poisoning will also give the patient’s immune system time to function. The fact that such natural compounds show strong antimicrobial effects against pathogens that are resistant to many antibiotics is promising. Some postbiotics, such as nisin, are classified GRAS by the FDA. The possibility of postbiotics developing antibiotic resistance or transferring resistance genes is a particularly noteworthy area of research. In this study, purified bacteriocins were not used. However, in analyses of postbiotics, supernatants were pre-treated to eliminate potential effects other than bacteriocins, such as high acidity, low pH, and the antimicrobial effect of hydrogen peroxide. It was determined that the antimicrobial effect originated from one or more proteins of a protein nature. The research results show that postbiotics passed the test in terms of antimicrobial effect, even without using pure bacteriocin. Although the MICs of postbiotics at 60–80% appear relatively high, their application in the poultry industry seems feasible in terms of economic cost, as they would not require purification expenses like bacteriocins. In the food industry, MIC and MBC values are important in many respects in studies on alternative antimicrobial agents. MIC concentrations are important for preventing or delaying microbial spoilage in foods and for extending the existing shelf-life of foods. MBC values are important for ensuring food safety by preventing the growth of pathogens in high-risk foods. In this study, the most influential factors affecting the applicability of the determined MIC and MBC values in the poultry sector are the food matrix and the applied technological processes. Certainly, when it comes to proposing the use of postbiotics as alternative antimicrobial agents in the poultry sector, evaluations are needed through in vivo studies with respect to the relationship between the food matrix and the application technique. Since postbiotics are resistant even at autoclave temperatures, they can be added to the boiling water; they can be used during the spraying stage as they do not cause color or odor changes; or they can be applied directly to meats before packaging. Industry-specific research is needed to determine at what stage, in what dosage, and by what method these postbiotic compounds should be used in the poultry sector.

5. Conclusions

The present study highlights the high prevalence of ESBL-positive E. coli in chicken meat and underscores the pressing public health challenge posed by antibiotic-resistant foodborne pathogens. Our findings demonstrate that postbiotics derived from Lb. plantarum and Lc. lactis strains isolated from kefir exhibit significant antimicrobial activity against both reference and ESBL-positive E. coli strains. Notably, Lb. plantarum postbiotics exerted both bacteriostatic and bactericidal effects, whereas Lc. lactis postbiotics showed primarily bacteriostatic activity, emphasizing their potential as natural alternatives to conventional antibiotics. The stability of postbiotic antimicrobial activity under various environmental conditions, including high temperatures, and their effectiveness against multidrug-resistant bacteria, further support their applicability in food safety and public health contexts. While the proportion of effective isolates was limited, the results indicate that postbiotics could be strategically employed in poultry processing to reduce pathogen load, thereby mitigating the risk of foodborne infections. Future studies should focus on optimizing application methods, dosages, and industrial-scale implementation, as well as investigating the mechanisms underlying the differential antimicrobial effects of bacteriocins. Overall, this research provides compelling evidence for the integration of postbiotic-based interventions in the poultry industry, offering a promising and sustainable approach to combat antibiotic-resistant pathogens and enhance food safety.

Author Contributions

Ç.S.: Conceptualization, methodology, software, validation, formal analysis, research, sources, data collection, writing, original draft preparation, writing—review and editing. N.B.: Research, writing—review and editing. G.D.B.: Research. M.A.A.: Statistical analysis. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Roth, N.; Käsbohrer, A.; Mayrhofer, S.; Zitz, U.; Hofacre, C.; Domig, K.J. The application of antibiotics in broiler production and the resulting antibiotic resistance in Escherichia coli: A global overview. Poult. Sci. 2019, 98, 1791–1804. [Google Scholar] [CrossRef]
  2. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; Wellcome Trust: London, UK, 2016; Available online: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf (accessed on 10 October 2025).
  3. Poole, T.; Sheffield, C. Use and misuse of antimicrobial drugs in poultry and livestock: Mechanisms of antimicrobial resistance. Pak. Vet. J. 2013, 33, 266–271. Available online: https://www.pvj.com.pk/pdf-files/33_3/266-271.pdf (accessed on 2 May 2025).
  4. Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition. Off. J. Eur. Union 2003, L268, 29–43. Available online: http://data.europa.eu/eli/reg/2003/1831/oj (accessed on 2 May 2025).
  5. FDA. Veterinary Feed Directive. Fed. Regist. 2015, 80, 31708–31735. Available online: https://www.federalregister.gov/documents/2015/06/03/2015-13393/veterinary-feed-directive (accessed on 2 May 2025).
  6. OECD-FAO. OECD-FAO Agricultural Outlook 2022–2031; OECD Publishing: Paris, France, 2022. [Google Scholar] [CrossRef]
  7. Randall, L.P.; Lodge, M.P.; Elviss, N.C.; Lemma, F.L.; Hopkins, K.L.; Teale, C.J.; Woodford, N. Evaluation of meat, fruit and vegetables from retail stores in five United Kingdom regions as sources of extended-spectrum beta-lactamase (ESBL)-producing and carbapenem-resistant Escherichia coli. Int. J. Food Microbiol. 2017, 241, 283–290. [Google Scholar] [CrossRef]
  8. Habib, I.; Elbediwi, M.; Mohamed, M.Y.I.; Ghazawi, A.; Abdalla, A.; Khalifa, H.O.; Khan, M. Enumeration, antimicrobial resistance and genomic characterization of ESBL-producing Escherichia coli from chicken meat. Int. J. Food Microbiol. 2023, 398, 110220. [Google Scholar] [CrossRef] [PubMed]
  9. Kelbert, L.; Barmettler, K.; Biggel, M.; Stephan, R.; Nüesch-Inderbinen, M. Occurrence and characteristics of extended-spectrum ß-lactamase-producing Escherichia coli in Swiss and imported retail chicken meat. J. Glob. Antimicrob. Resist. 2025, 43, 285–292. [Google Scholar] [CrossRef] [PubMed]
  10. Wallace, R.L.; Hoogstra, S.; Mahoney, D.; Lubberts, M.; Reid-Smith, R.; Signorelli, T.; Robertson, J.; Eagle, S.H.C.; Jurga, E.; Nash, J.; et al. Genomic characterization of pathotype diversity and drug resistance among generic Escherichia coli isolated from broiler chickens in Canada. Can. J. Microbiol. 2025, 71, 1–13. [Google Scholar] [CrossRef]
  11. Martínez-Álvarez, S.; Châtre, P.; François, P.; Zarazaga, M.; Madec, J.Y.; Haenni, M.; Torres, C. Comparative phylogenomics of extended-spectrum beta-lactamase-producing Escherichia coli revealed a wide diversity of clones and plasmids in Spanish chicken meat. Int. J. Food Microbiol. 2025, 426, 110900. [Google Scholar] [CrossRef]
  12. Kabir, M.; Yahaya, M.S.; Uhuami, A.O.; Yakubu, Y.; Jibril, A.H. Molecular prevalence of extended spectrum beta lactamase producing Escherichia coli in dressed broiler chickens in Sokoto metropolis. Microbe 2025, 8, 100434. [Google Scholar] [CrossRef]
  13. Tsitsos, A.; Damianos, A.; Tsiouris, V.; Papapanagiotou, E.; Soultos, N.; Papa, A.; Tyrodimos, A.; Economou, V. Prevalence, seasonal variation, and proteomic relationship of β-lactamase-producing Escherichia coli, Klebsiella pneumoniae, and Acinetobacter spp. in poultry meat at the abattoir level in Greece. Food Microbiol. 2025, 128, 104709. [Google Scholar] [CrossRef]
  14. Schwaiger, K.; Huther, S.; Hölzel, C.; Kämpf, P. Prevalence of antibiotic-resistant enterobacteriaceae isolated from chicken and pork meat purchased at the slaughterhouse and at retail in Bavaria, Germany. Int. J. Food Microbiol. 2012, 154, 206–211. [Google Scholar] [CrossRef] [PubMed]
  15. Kim, S.; Kim, H.; Kim, Y.; Kim, M.; Kwak, H.; Ryu, S. Antimicrobial resistance of Escherichia coli from retail poultry meats in Korea. J. Food Prot. 2020, 83, 1673–1678. [Google Scholar] [CrossRef]
  16. Chalmers, G.; Cobean, J.; Snyder, R.P.; Barta, J.R.; Boerlin, P. Extended-spectrum cephalosporin resistance in Escherichia coli from broiler chickens raised with or without antibiotics in Ontario, Canada. Vet. Microbiol. 2021, 258, 109116. [Google Scholar] [CrossRef] [PubMed]
  17. Projahn, M.; Tippelskirch, P.V.; Semmler, T.; Guenther, S.; Alter, T.; Roesler, U. Contamination of chicken meat with extended-spectrum beta-lactamase producing- Klebsiella pneumoniae and Escherichia coli during scalding and defeathering of broiler carcasses. Food Microbiol. 2019, 77, 185–191. [Google Scholar] [CrossRef] [PubMed]
  18. Zhao, W.; Wan, S.; Li, S.; Li, W.; Kang, J.; Liu, Y.; Huang, H.; Li, H.; Du, Z.D.; Xu, C.; et al. Research note: Characteristics of blaNDM and mcr-1 co-producing Escherichia coli from retail chicken meat. Poult. Sci. 2024, 103, 104160. [Google Scholar] [CrossRef]
  19. World Health Organization. Ten Global Health Issues to Track in 2021. 2021. Available online: https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021 (accessed on 2 May 2025).
  20. Castellano, P.; Vignolo, G. Inhibition of Listeria innocua and Brochothrix thermosphacta in vacuum-packaged meat by addition of bacteriocinogenic Lactobacillus curvatus CRL705 and its bacteriocins. Lett. Appl. Microbiol. 2006, 43, 194–199. [Google Scholar] [CrossRef]
  21. Abanoz, H.S.; Kunduhoglu, B. Antimicrobial Activity of a Bacteriocin Produced by Enterococcus faecalis KT11 against Some Pathogens and Antibiotic-Resistant Bacteria. Korean J. Food Sci. Anim. Resour. 2018, 38, 1064–1079. [Google Scholar] [CrossRef]
  22. Bashir, A.; Ali, K. Antagonistic Activity of Bacteriocins Produced by Lactobacillus Isolates against Multidrug Resistant Pathogens. J. Pharm. Res. Int. 2021, 33, 76–87. [Google Scholar] [CrossRef]
  23. Hasan, M.M.; Fahim, F.J.; Rana, S.; Uddin, S.; Tonny, M.F.S.; Sarkar, S.; Zinnah, K.; Hossain, F.M.A. Antimicrobial potential and stability of Lactobacillus acidophilus-derived bacteriocins against multidrug-resistant common foodborne pathogens. Appl. Food Res. 2025, 5, 100728. [Google Scholar] [CrossRef]
  24. Feng, P.; Weagant, S.D.; Grant, M.A.; Burkhardt, W. Bacteriological Analytical Manual. Chapter 4. Enumeration of Escherichia coli and the Coliform Bacteria. 2002 Revision 2020. Available online: https://www.fda.gov/media/182572/download?attachment (accessed on 2 May 2025).
  25. Sezer, C.; Güven, A. Investigation of Bacteriocin Production Capability of Lactic Acid Bacteria Isolated from Foods. Kafkas Univ. Vet. Fak. Derg. 2009, 15, 45–50. [Google Scholar] [CrossRef]
  26. Kandler, O.; Weiss, N. Regular, Nonsporing Gram positive rods. Genus Lactobacillus. In Bergey’s Manual of Systematic Bacteriology; Sneath, P.H.A., Mair, N.S., Sharpe, M.E., Holt, J.G., Eds.; Williams & Wilkins: Baltimore, MD, USA, 1986; Volume 2, pp. 1208–1234. [Google Scholar]
  27. Torriani, S.; Felis, G.E.; Dellaglio, F. Differentiation of Lactobacillus plantarum, L. pentosus, and L. paraplantarum by recA gene sequence analysis and multiplex PCR assay with recA genederived primers. App. Environ. Microbiol. 2001, 67, 3450–3454. [Google Scholar] [CrossRef]
  28. Pu, Z.Y.; Dobos, M.; Limsowtin, G.K.Y.; Powell, I.B. Integrated polymerase chain reaction-based procedures for the detection and identification of species and subspecies of the Gram positive bacterial genus Lactococcus. J. Appl. Microbiol. 2002, 93, 353–361. [Google Scholar] [CrossRef]
  29. Sezer, C.; Güven, A.; Oral Bilge, N.; Vatansever, L. Detoxification of Aflatoxin B1 by Bacteriocins and Bacteriocinogenic Lactic Acid Bacteria. Turk. J. Vet. Anim. Sci. 2013, 37, 594–601. [Google Scholar] [CrossRef]
  30. CLSI M100; Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2024.
  31. EUCAST. European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 15.0. 2025. Available online: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_15.0_Breakpoint_Tables.pdf (accessed on 15 October 2025).
  32. EUCAST. European Committee on Antimicrobial Susceptibility Testing. Antimicrobial Susceptibility Testing EUCAST Disk Diffusion Method, Version 13.0. 2025. Available online: https://www.eucast.org/bacteria/methodology-and-instructions/disk-diffusion-and-quality-control/ (accessed on 15 October 2025).
  33. EUCAST. European Committee on Antimicrobial Susceptibility Testing. Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance. Version 2.0. 2017. Available online: https://www.eucast.org/fileadmin/eucast/pdf/eucast_guidelines/EUCAST_detection_of_resistance_mechanisms_170711.pdf (accessed on 2 May 2025).
  34. CLSI M07; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2018.
  35. Centers for Disease Control and Prevention. Healthcare Provider Information on Foodborne Illness. 2024. Available online: https://www.cdc.gov/food-safety/hcp/information/index.html (accessed on 15 October 2025).
  36. WHO. World Health Organization. Food Safety. 4 October 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/food-safety (accessed on 15 October 2025).
  37. WHO (World Health Organization). Bacterial Priority Pathogens List. Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance; WHO: Geneva, Switzerland, 2024; ISBN 978-92-4-009346-1. Available online: https://www.who.int/publications/i/item/9789240093461 (accessed on 15 October 2025).
  38. Pehlivanlar Önen, S.; Aslantaş, Ö.; Yılmaz, E.Ş.; Kürekci, C. Prevalence of β-Lactamase Producing Escherichia coli from Retail Meat in Turkey. J. Food Sci. 2015, 80, 2023–2029. [Google Scholar] [CrossRef]
  39. Randall, L.P.; Horton, R.H.; Chanter, J.I.; Lemma, F.; Evans, S.J. A decline in the occurrence of extended-spectrum β-lactamase-producing Escherichia coli in retail chicken meat in the UK between 2013 and 2018. J. Appl. Microbiol. 2021, 130, 247–257. [Google Scholar] [CrossRef] [PubMed]
  40. Aydin, A.; Suleymanoglu, A.A.; Abdramanov, A.; Paulsen, P.; Dumen, E. Detection of Extended Spectrum ß-Lactamase-Producing Escherichia coli with Biofilm Formation from Chicken Meat in Istanbul. Foods 2024, 13, 1122. [Google Scholar] [CrossRef]
  41. Rouger, A.; Tresse, O.; Zagorec, M. Bacterial Contaminants of Poultry Meat: Sources, Species, and Dynamics. Microorganisms 2017, 5, 50. [Google Scholar] [CrossRef] [PubMed]
  42. Chowdhury, M.A.H.; Ashrafudoulla, M.; Mevo, S.I.U.; Mizan, M.F.R.; Park, S.H.; Ha, S.D. Current and future interventions for improving poultry health and poultry food safety and security: A comprehensive review. Compr. Rev. Food Sci. Food Saf. 2023, 22, 1555–1596. [Google Scholar] [CrossRef] [PubMed]
  43. Chaluvadi, S.; Hotchkiss, A.T.; Yam, K.L. Gut Microbiota: Impact of Probiotics, Prebiotics, Synbiotics, Pharmabiotics, and Postbiotics on Human Health. Chapter 36. In Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion; Watson, R.R., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2016; pp. 515–523. ISBN 9780128021897. [Google Scholar] [CrossRef]
  44. Piqué, N.; Berlanga, M.; Miñana-Galbis, D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int. J. Mol. Sci. 2019, 20, 2534. [Google Scholar] [CrossRef]
  45. Safari, M.S.; Keyhanfar, M.; Shafiei, R. Investigating the antibacterial effects of some Lactobacillus, Bifidobacterium and acetobacter strains killed by different methods on Streptococcus mutans and Escherichia coli. Mol. Biol. Res. Commun. 2019, 8, 103–111. [Google Scholar] [CrossRef] [PubMed]
  46. Yordshahi, A.S.; Moradi, M.; Tajik, H.; Molaei, R. Design and preparation of antimicrobial meat wrapping nanopaper with bacterial cellulose and postbiotics of lactic acid bacteria. Int. J. Food Microbiol. 2020, 321, 108561. [Google Scholar] [CrossRef] [PubMed]
  47. Mani-López, E.; Arrioja-Bretón, D.; López-Malo, A. The impacts of antimicrobial and antifungal activity of cell-free supernatants from lactic acid bacteria in vitro and foods. Compr. Rev. Food Sci. Food Saf. 2022, 21, 604–641. [Google Scholar] [CrossRef] [PubMed]
  48. Helander, I.M.; Mattila-Sandholm, T. Permeability barrier of the gram-negative bacterial outer membrane with special reference to nisin. Int. J. Food Microbiol. 2000, 60, 153–161. [Google Scholar] [CrossRef]
  49. Bierbaum, G.; Sahl, H.G. Lantibiotics: Mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 2009, 10, 2–18. [Google Scholar] [CrossRef]
  50. Guirguis, E. Enhancıng the antıbacterıal effect of bacterıocın from lactococcus lactıs subsp. Lactıs usıng chıtosan nanopartıcles. J. Microbiol. Biotechnol. Food Sci. 2021, 11, 3777. [Google Scholar] [CrossRef]
  51. Wiedemann, I.; Breukink, E.; van Kraaij, C.; Kuipers, O.P.; Bierbaum, G.; de Kruijff, B.; Sahl, H.G. Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity. J. Biol. Chem. 2001, 276, 1772–1779. [Google Scholar] [CrossRef]
  52. Drider, D.; Fimland, G.; Héchard, Y.; McMullen, L.M.; Prévost, H. The continuing story of class IIa bacteriocins. Microbiol. Mol. Biol. Rev. 2006, 70, 564–582. [Google Scholar] [CrossRef]
  53. Wiedemann, I.; Böttiger, T.; Bonelli, R.R.; Schneider, T.; Sahl, H.G.; Martínez, B. Lipid II-Based Antimicrobial Activity of the Lantibiotic Plantaricin C. Appl. Environ. Microbiol. 2006, 72, 2809–2814. [Google Scholar] [CrossRef]
  54. Nissen-Meyer, J.; Oppegård, C.; Rogne, P.; Haugen, H.S.; Kristiansen, P.E. Structure and Mode-of-Action of the Two-Peptide (Class-IIb) Bacteriocins. Probiotics Antimicrob. Prot. 2010, 2, 52–60. [Google Scholar] [CrossRef]
  55. Islam, M.R.; Nishie, M.; Nagao, J.; Zendo, T.; Keller, S.; Nakayama, J.; Kohda, D.; Sahl, H.-G.; Sonomoto, K. Ring A of Nukacin ISK-1: A Lipid II-Binding Motif for Type-A(II) Lantibiotic. J. Am. Chem. Soc. 2012, 134, 3687–3690. [Google Scholar] [CrossRef] [PubMed]
  56. Pérez-Ramos, A.; Madi-Moussa, D.; Coucheney, F.; Drider, D. Current Knowledge of the Mode of Action and Immunity Mechanisms of LAB-Bacteriocins. Microorganisms 2021, 9, 2107. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The antimicrobial susceptibility and resistance profile of E. coli isolates.
Figure 1. The antimicrobial susceptibility and resistance profile of E. coli isolates.
Foods 15 00384 g001
Table 1. Primers used for the identification of lactic acid bacteria.
Table 1. Primers used for the identification of lactic acid bacteria.
BacteriaPrimer SequencesBand SizeReferences
Lb. plantarumplan F (5′-CCG TTT ATG CGG AAC ACC TA-3′)
pREV (5′-TCG GGA TTA CCA AAC ATC AC-3′)
318 bp[27]
Lc. lactisLacreR (19-GGGATCATCTTTGAGTGAT)
LacF (19-GTACTTGTACCGACTGGAT)
161 bp[28]
Table 2. Antimicrobial susceptibility of E. coli isolates.
Table 2. Antimicrobial susceptibility of E. coli isolates.
E. coli Isolates (%)
Antibiotic GroupAntibiotic AgentsResistantSusceptible
PenicillinAmpicillin (10 µg)100% (n = 125)0% (n = 0)
Beta-Lactamase Inhibitor/penicillinTicarcillin/Clavulanate (75–10 µg)30.4% (n = 38)69.6% (n = 87)
CephalosporinsCefoxitin (30 µg)100% (n = 125)0% (n = 0)
Ceftriaxone (30 µg)62.4% (n = 78)37.6% (n = 47)
Cefotaxime (5 µg) 48% (n = 60)52% (n = 65)
Cephalothin (30 µg)100% (n = 125)0% (n = 0)
Ceftazidime (10 µg) 39.2% (n = 49)60.8% (n = 76)
Cefpodoxime (10 µg)28% (n = 35)72% (n = 90)
FluoroquinolonesCiprofloxacin (5 µg)40% (n = 50)60% (n = 75)
AntimicrobicTrimethoprim/sulfamethoxazole (125–23.75 µg) 41.6% (n = 52)58.4% (n = 73)
Chloramphenicol (30 µg)36.8% (n = 46)63.2% (n = 79)
Carbapenem Meropenem (10 µg)0% (n = 0)100% (n = 125)
Monobactam Aztreonam (30 µg)100% (n = 125)0% (n = 0)
AminoglycosideGentamicin (10 µg) 0.8% (n = 1)99.2% (n = 124)
Amikacin (30 µg)0.8% (n = 1)99.2% (n = 124)
Netilmicin (10 µg)10.4% (n = 13)89.6% (n = 112)
Table 3. Concentration- and time-dependent antimicrobial effects of postbiotics produced by Lb. plantarum.
Table 3. Concentration- and time-dependent antimicrobial effects of postbiotics produced by Lb. plantarum.
Lb. plantarum Postbiotics (Concentration %)
Foods 15 00384 i001
0 = growth not detected, 1= growth detected.
Table 4. Concentration- and time-dependent antimicrobial effects of postbiotics produced by Lc. lactis.
Table 4. Concentration- and time-dependent antimicrobial effects of postbiotics produced by Lc. lactis.
Lc. lactis Postbiotics (Concentration %)
Foods 15 00384 i002
0 = Growth not detected; 1= growth detected.
Table 5. Descriptive statistics of the continuous variables used in the study.
Table 5. Descriptive statistics of the continuous variables used in the study.
VariableNMedian ± SEQ1–Q3Minimum–Maximum
Concentration (%)649820.00 ± 0.432.50–60.001.25–100
Incubation time (hour)649818.00 ± 0.316.00–48.000–72
SE: Standard error; Q1–Q3: interquartile range.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sezer, Ç.; Bilge, N.; Büyük, G.D.; Ayyıldız Akın, M. Antimicrobial Effect of Postbiotics on Multidrug-Resistant Escherichia coli. Foods 2026, 15, 384. https://doi.org/10.3390/foods15020384

AMA Style

Sezer Ç, Bilge N, Büyük GD, Ayyıldız Akın M. Antimicrobial Effect of Postbiotics on Multidrug-Resistant Escherichia coli. Foods. 2026; 15(2):384. https://doi.org/10.3390/foods15020384

Chicago/Turabian Style

Sezer, Çiğdem, Nebahat Bilge, Gönül Damla Büyük, and Merve Ayyıldız Akın. 2026. "Antimicrobial Effect of Postbiotics on Multidrug-Resistant Escherichia coli" Foods 15, no. 2: 384. https://doi.org/10.3390/foods15020384

APA Style

Sezer, Ç., Bilge, N., Büyük, G. D., & Ayyıldız Akın, M. (2026). Antimicrobial Effect of Postbiotics on Multidrug-Resistant Escherichia coli. Foods, 15(2), 384. https://doi.org/10.3390/foods15020384

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop